Transcriptional repression of WEE1 by Kruppel-like factor 2 is involved in DNA damage-induced apoptosis

Oncogene

Volumn 24, Issue 24, 2005, Pages 3875-3885

  Wang, Fang ^a   Zhu, Yu ^a   Huang, Yan ^a   McAvoy, Sarah ^a   Johnson, William B ^a   Cheung, Tak Hong ^b   Chung, Tony Kwok Hung ^b   Lo, Keith Wing Kit ^b   Yim, So Fan ^b   Yu, May M Y ^c   Ngan, Hextan Y S ^b   Wong, Yick Fu ^b   Smith, David I ^a,d  

^a Mayo Clinic College of Medicine   (United States)

^b CHINESE UNIVERSITY OF HONG KONG   (Hong Kong)

^c CHINESE UNIVERSITY OF HONG KONG   (Hong Kong)

^d MAYO CLINIC CANCER CENTER   (United States)

Author keywords

KLF2; Transcriptional regulation; WEE1

Indexed keywords

CYSTEINE; HISTIDINE; KRUPPEL LIKE FACTOR 2; PROTEIN TYROSINE KINASE; PROTEIN WEE1; TRANSCRIPTION FACTOR; UNCLASSIFIED DRUG; ZINC FINGER PROTEIN; CELL CYCLE PROTEIN; KLF2 PROTEIN, HUMAN; KRUPPEL LIKE FACTOR; NUCLEAR PROTEIN; TRANSACTIVATOR PROTEIN; WEE1 PROTEIN, HUMAN;

APOPTOSIS; ARTICLE; CELL CYCLE G2 PHASE; CELL CYCLE PHASE; CELL GROWTH; CONTROLLED STUDY; DNA DAMAGE; DNA FINGERPRINTING; ENZYME REGULATION; GENE EXPRESSION REGULATION; HUMAN; HUMAN CELL; OVARY CANCER; PHASE TRANSITION; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN DOMAIN; PROTEIN EXPRESSION; PROTEIN TARGETING; SENSITIVITY ANALYSIS; TRANSCRIPTION REGULATION; CELL LINE; FEMALE; GENETIC TRANSCRIPTION; GENETICS; METABOLISM; MOLECULAR CLONING; NUCLEOTIDE SEQUENCE; OVARY; OVARY TUMOR; PHYSIOLOGY; TUMOR CELL LINE;

APOPTOSIS; BASE SEQUENCE; CELL CYCLE PROTEINS; CELL LINE; CELL LINE, TUMOR; CLONING, MOLECULAR; DNA DAMAGE; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; KRUPPEL-LIKE TRANSCRIPTION FACTORS; NUCLEAR PROTEINS; OVARIAN NEOPLASMS; OVARY; PROMOTER REGIONS (GENETICS); PROTEIN-TYROSINE KINASES; TRANS-ACTIVATORS; TRANSCRIPTION, GENETIC; ZINC FINGERS;

EID: 20544468698     PISSN: 09509232     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.onc.1208546     Document Type: Article

References (32)

1. Banerjee SS, Feinberg MW, Watanabe M, Gray S, Haspel RL, Denkinger DJ, Kawahara R, Hauner H and Jain MK. (2003). J. Biol. Chem., 278, 2581-2584.
2. Benzeno S, Narla G, Allina J, Cheng GZ, Reeves HL, Banck MS, Odin JA, Diehl JA, Germain D and Friedman SL. (2004). Cancer Res., 64, 3885-3891.
3. Bieker JJ. (2001). J. Biol. Chem., 276, 34355-34358.
4. Black AR, Black JD and Azizkhan-Clifford J. (2001). J. Cell. Physiol., 188, 143-160.
5. Buckley AF, Kuo CT and Leiden JM. (2001). Nat. Immunol., 2, 698-704.
6. Chen C, Hyytinen ER, Sun X, Helin HJ, Koivisto PA, Frierson Jr HF, Vessella RL and Dong JT. (2003a). Am. J. Pathol., 162, 1349-1354.
7. Chen X, Whitney EM, Gao SY and Yang VW. (2003b). J. Mol. Biol., 326, 665-677.
8. Dekker RJ, van Soest S, Fontijn RD, Salamanca S, de Groot PG, VanBavel E, Pannekoek H and Horrevoets AJ. (2002). Blood, 100, 1689-1698.
9. Denkinger DJ, Cushman-Vokoun AM and Kawahara RS. (2001). Gene, 281, 133-142.
10. Dent P and Grant S. (2001). Clin. Cancer Res., 7, 775-783.
11. Elder RT, Yu M, Chen M, Zhu X, Yanagida M and Zhao Y. (2001). Virology, 287, 359-370.
12. Huddleson JP, Srinivasan S, Ahmad N and Lingrel JB. (2004). Biol. Chem., 385, 723-729.
13. Ito G, Uchiyama M, Kondo M, Mori S, Usami N, Maeda O, Kawabe T, Hasegawa Y, Shimokata K and Sekido Y. (2004). Cancer Res., 64, 3838-3843.
14. Kimmelman AC, Qiao RF, Narla G, Banno A, Lau N, Bos PD, Nunez Rodriguez N, Liang BC, Guha A, Martignetti JA, Friedman SL and Chan AM. (2004). Oncogene, 23, 5077-5083.
15. Kremer-Tal S, Reeves HL, Narla G, Thung SN, Schwartz M, Difeo A, Katz A, Bruix J, Bioulac-Sage P, Martignetti JA and Friedman SL. (2004). Hepatology, 40, 1047-1052.
16. Kuo CT, Veselits ML, Barton KP, Lu MM, Clendenin C and Leiden JM. (1997). Genes Dev., 11, 2996-3006.
17. Lai J, Chien J, Staub J, Avula R, Greene EL, Matthews TA, Smith DI, Kaufmann SH, Roberts LR and Shridhar V. (2003). J. Biol. Chem., 278, 23107-23117.
18. Li J, Wang Y, Sun Y and Lawrence TS. (2002). Radiat. Res., 157, 322-330.
19. Narla G, Heath KE, Reeves HL, Li D, Giono LE, Kimmelman AC, Glucksman MJ, Narla J, Eng FJ, Chan AM, Ferrari AC, Martignetti JA and Friedman SL. (2001). Science, 294, 2563-2566.
20. Pandya AY, Talley LI, Frost AR, Fitzgerald TJ, Trivedi V, Chakravarthy M, Chhieng DC, Grizzle WE, Engler JA, Krontiras H, Bland KI, LoBuglio AF, Lobo-Ruppert SM and Ruppert JM. (2004). Clin. Cancer Res., 10, 2709-2719.
21. Pendergast AM. (1996). Curr. Opin. Cell Biol., 8, 174-181.
22. Reeves HL, Narla G, Ogunbiyi O, Haq AI, Katz A. Benzeno S, Hod E, Harpaz N, Goldberg S, Tal-Kremer S, Eng FJ, Arthur MJ, Martignetti JA and Friedman SL. (2004). Gastroenterology, 126, 1090-1103.
23. Rowley R, Hudson J and Young PG. (1992). Nature, 356, 353-355.
24. SenBanerjee S, Lin Z, Atkins GB, Greif DM, Rao RM, Kumar A, Feinberg MW, Chen Z, Simon DI, Luscinskas FW, Michel TM, Gimbrone Jr MA, Garcia-Cardena G and Jain MK. (2004). J. Exp. Med., 199, 1305-1315.
25. Tourret J and McKeon F. (1996). Prog. Cell Cycle Res., 2, 91-97.
26. Vax VV, Gueorguiev M, Dedov II, Grossman AB and Korbonits M. (2003). Endocr. Relat. Cancer, 10, 397-402.
27. Wang Y, Decker SJ and Sebolt-Leopold J. (2004). Cancer Biol Ther., 3, 305-313.
28. Wu J and Lingrel JB. (2004). Oncogene, 23, 8088-8096.
29. Yoon HS, Chen X and Yang VW. (2003). J. Biol. Chem., 278, 2101-2105.
30. Yuan H, Kamata M, Xie YM and Chen IS. (2004). J. Virol., 78, 8183-8190.
31. Zhang W, Geiman DE, Shields JM, Dang DT, Mahatan CS, Kaestner KH, Biggs JR, Kraft AS and Yang VW. (2000). J. Biol. Chem., 275, 18391-18398.
32. Zhao W, Hisamuddin IM, Nandan MO, Babbin BA, Lamb NE and Yang VW. (2004). Oncogene, 23, 395-402.